Figure 1.
Flow chart of patients enrolled in this study, who progressed after front-line first- or second-generation EGFR-TKI treatment and underwent liquid biopsy to assess the T790M mutational status.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.